Carbachol dimers as homobivalent modulators of muscarinic receptors

Abstract

A series of homodimers of the well-known cholinergic agonist carbachol have been synthesized, showing the two agonist units symmetrically connected through a methylene chain of variable length. The new compounds have been tested on the five cloned muscarinic receptors (hM1-5) expressed in CHO cells by means of equilibrium binding studies, showing an increase in affinity by rising the number of methylene units up to 7 and 9. Functional experiments on guinea-pig ileum and assessment of ERK1/2 phosphorylation on hM1, hM2 and hM3 on CHO cells have shown that the new compounds are endowed with muscarinic antagonistic properties. Kinetic binding studies have revealed that some of the tested compounds are able to slow the rate of dissociation of NMS, suggesting a bitopic behavior. Docking simulations, performed on the hM1 and hM2 receptors, give a sound rationalization of the experimental data revealing how these compounds are able to interact with both orthosteric and allosteric binding sites depending on the length of their connecting chain.

Keywords: Acetylcholine chloride (PubChem CID: 6060); Allosteric modulation; Atropine sulfate (PubChem CID: 64663); Bivalent ligand; Carbachol; Carbachol chloride (PubChem CID: 5831); Gallamine triethiodide (PubChem CID: 6172); Hexamethonium chloride (PubChem CID: 93550); Muscarinic acetylcholine receptor.